XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
6.38
+0.04 (0.63%)
Dec 20, 2024, 4:00 PM EST - Market closed

XBiotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Net Income
-32.66-24.56-32.9-17.41-11.22668.63
Upgrade
Depreciation & Amortization
1.741.742.612.652.242.36
Upgrade
Stock-Based Compensation
1.813.265.064.4612.583.36
Upgrade
Other Operating Activities
0.18-1.892.8---675
Upgrade
Change in Accounts Receivable
---4.11-4.11-
Upgrade
Change in Accounts Payable
0.010.090.36-0.51-0.330.5
Upgrade
Change in Unearned Revenue
-----4.54.5
Upgrade
Change in Income Taxes
0.250.68.71-2.17-6.511.06
Upgrade
Change in Other Net Operating Assets
0.82.09-0.6576.91-3.98-72.59
Upgrade
Operating Cash Flow
-27.86-18.73-14.8269.45-65.15-18.27
Upgrade
Capital Expenditures
-1.34-0.36-0.59-3.53-3.73-0.2
Upgrade
Divestitures
-----675
Upgrade
Investment in Securities
-61.86-63.31---
Upgrade
Investing Cash Flow
-1.3461.5-63.89-3.53-3.73674.8
Upgrade
Issuance of Common Stock
0.170.01-810.2842.1
Upgrade
Repurchase of Common Stock
-----420-
Upgrade
Common Dividends Paid
----75--
Upgrade
Other Financing Activities
--0.01----
Upgrade
Financing Cash Flow
10.17-0.01--67.01-409.7242.1
Upgrade
Foreign Exchange Rate Adjustments
-0.05-0.05-0.960.711.370.15
Upgrade
Net Cash Flow
-19.0742.72-79.68-0.38-477.23698.77
Upgrade
Free Cash Flow
-29.19-19.09-15.4165.92-68.88-18.47
Upgrade
Free Cash Flow Margin
---384.26%358.38%-156.55%-
Upgrade
Free Cash Flow Per Share
-0.96-0.63-0.512.19-2.23-0.40
Upgrade
Cash Income Tax Paid
----54.09-
Upgrade
Levered Free Cash Flow
-23.61-16.1-6.3366-143.3842.76
Upgrade
Unlevered Free Cash Flow
-23.23-16.1-6.3366-143.3842.76
Upgrade
Change in Net Working Capital
-0.99-2.7-8.14-78.09143.05-56.77
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.